Seaport Therapeutics
@seaporttx.bsky.social
We're a clinical-stage biopharmaceutical company advancing the development of neuropsychiatric medicines in areas of high unmet patient needs.
Co‑founder & Board Chair Dr Steve Paul joined BioCentury's podcast to discuss the past, present & future of neuropsychiatric drug development – from the depression space to potential of psychedelics - & what we’re building at Seaport w/our Glyph platform: bit.ly/4r2gRCy
Serendipity drives discovery in psychiatry, engineering gets it across the line, says Steve Paul
With disease biology still murky and trials notoriously noisy, psychiatry R&D is advancing fastest where teams can solve engineering problems. Delivery...
bit.ly
February 12, 2026 at 12:00 PM
Co‑founder & Board Chair Dr Steve Paul joined BioCentury's podcast to discuss the past, present & future of neuropsychiatric drug development – from the depression space to potential of psychedelics - & what we’re building at Seaport w/our Glyph platform: bit.ly/4r2gRCy
Our Seaport team started the year w/a gathering to celebrate the holidays & reflect on our progress last year. It was great to connect as a team & we're excited to carry this energy through 2026 as we continue our mission to serve those impacted by #neuropsychiatric conditions.
February 5, 2026 at 12:00 PM
Our Seaport team started the year w/a gathering to celebrate the holidays & reflect on our progress last year. It was great to connect as a team & we're excited to carry this energy through 2026 as we continue our mission to serve those impacted by #neuropsychiatric conditions.
Co-founder & CEO @daphnezohar.bsky.social presented at #JPM26 sharing our recent progress & path forward as we tackle some of the biggest medical problems our population is facing today. Co-founders Steve Paul (Chair) & Michael Chen (CSO) joined for Q&A. #depression #anxiety #neuropsychiatry
January 13, 2026 at 12:02 PM
Co-founder & CEO @daphnezohar.bsky.social presented at #JPM26 sharing our recent progress & path forward as we tackle some of the biggest medical problems our population is facing today. Co-founders Steve Paul (Chair) & Michael Chen (CSO) joined for Q&A. #depression #anxiety #neuropsychiatry
Our Co-founder & CEO, @daphnezohar.bsky.social, will present at #JPM26 on Jan. 12 at 9:30AM PT. She’ll be joined by Steve Paul, M.D., Co-founder & Chair & Michael Chen, Ph.D., Co-founder & CSO, during the Q&A portion of the presentation. bit.ly/3NsW6kt
January 5, 2026 at 12:00 PM
Our Co-founder & CEO, @daphnezohar.bsky.social, will present at #JPM26 on Jan. 12 at 9:30AM PT. She’ll be joined by Steve Paul, M.D., Co-founder & Chair & Michael Chen, Ph.D., Co-founder & CSO, during the Q&A portion of the presentation. bit.ly/3NsW6kt
This year, we've made meaningful progress at Seaport from clinical milestones w/ the Ph2b BUOY‑1 study of GlyphAllo™ in #MDD (w/ or w/o anxious distress) & a Ph1 study of GlyphAgo™ for treatment of #GAD to moments together, made possible by our incredible team. #HappyHolidays!
December 23, 2025 at 12:05 PM
This year, we've made meaningful progress at Seaport from clinical milestones w/ the Ph2b BUOY‑1 study of GlyphAllo™ in #MDD (w/ or w/o anxious distress) & a Ph1 study of GlyphAgo™ for treatment of #GAD to moments together, made possible by our incredible team. #HappyHolidays!
Today at 10AM ET our CFO, Lauren White, & CSO, Michael Chen, PhD, will present at the RBC Capital Markets Healthcare Private Company Conference. Members of our team will also participate in 1x1 meetings.
Tune in: bit.ly/4a5zsYR
Replays: bit.ly/3MokeEE
Tune in: bit.ly/4a5zsYR
Replays: bit.ly/3MokeEE
December 11, 2025 at 12:00 PM
Today at 10AM ET our CFO, Lauren White, & CSO, Michael Chen, PhD, will present at the RBC Capital Markets Healthcare Private Company Conference. Members of our team will also participate in 1x1 meetings.
Tune in: bit.ly/4a5zsYR
Replays: bit.ly/3MokeEE
Tune in: bit.ly/4a5zsYR
Replays: bit.ly/3MokeEE
#AES25: Data further validate Glyph’s ability to enhance oral bioavailability & expand therapeutic reach w/ successful application of Glyph to another class of clinically validated molecules previously held back by limitations Glyph’s designed to solve. bit.ly/44K0BwW
December 8, 2025 at 12:02 PM
#AES25: Data further validate Glyph’s ability to enhance oral bioavailability & expand therapeutic reach w/ successful application of Glyph to another class of clinically validated molecules previously held back by limitations Glyph’s designed to solve. bit.ly/44K0BwW
Members of our management team will present at the 2025 RBC Capital Markets Healthcare Private Company Conference on Dec. 11 at 10AM ET & will participate in 1x1 meetings at the conference.
Press release: bit.ly/3XTj7PT
Live & archived webcast: seaporttx.com/news-papers/
Press release: bit.ly/3XTj7PT
Live & archived webcast: seaporttx.com/news-papers/
December 4, 2025 at 12:01 PM
Members of our management team will present at the 2025 RBC Capital Markets Healthcare Private Company Conference on Dec. 11 at 10AM ET & will participate in 1x1 meetings at the conference.
Press release: bit.ly/3XTj7PT
Live & archived webcast: seaporttx.com/news-papers/
Press release: bit.ly/3XTj7PT
Live & archived webcast: seaporttx.com/news-papers/
Team members joined @afspnational.bsky.social “Out of the Darkness” walk in Boston to raise awareness for suicide prevention. Our CMO, Tony Loebel, serves on AFSP's board, aligning w/ our mission to serve those w/ #mentalhealth conditions like #depression & #anxiety. Hear more from Tony!
December 1, 2025 at 12:51 PM
Team members joined @afspnational.bsky.social “Out of the Darkness” walk in Boston to raise awareness for suicide prevention. Our CMO, Tony Loebel, serves on AFSP's board, aligning w/ our mission to serve those w/ #mentalhealth conditions like #depression & #anxiety. Hear more from Tony!
Our CEO @daphnezohar joined the Making Medicine podcast to talk biotech, policy, & Seaport’s mission. Her take on price controls? The real impact would fall on patients, who are at the center of our work at Seaport. Hear her response in the full episode: www.youtube.com/watch?v=ICsz...
Making Medicine ft. Daphne Zohar. Biotech Flywheels, Policy Risks, and the Future of Innovation.
YouTube video by Making Medicine
www.youtube.com
November 26, 2025 at 2:08 PM
Our CEO @daphnezohar joined the Making Medicine podcast to talk biotech, policy, & Seaport’s mission. Her take on price controls? The real impact would fall on patients, who are at the center of our work at Seaport. Hear her response in the full episode: www.youtube.com/watch?v=ICsz...
#HappyThanksgiving! Ahead of the holiday, we assembled care packages for Rosie's Place - a women's shelter in Boston - & enjoyed time together at a holiday lunch. Giving back reminds us that we're here to serve those living w/ #mentalhealth conditions like #depression & #anxiety.
November 26, 2025 at 12:22 PM
#HappyThanksgiving! Ahead of the holiday, we assembled care packages for Rosie's Place - a women's shelter in Boston - & enjoyed time together at a holiday lunch. Giving back reminds us that we're here to serve those living w/ #mentalhealth conditions like #depression & #anxiety.
Today Co-Founder & Board Chair Dr. Steve Paul joins Technology Innovation Studio’s Breakthrough Biotech Builders fireside chat on his role in the dev of CNS blockbusters Zyprexa®, Cymbalta® and Cobenfy™ (KarXT) which originated at PureTech (founded/led by @daphnezohar.bsky.social) luma.com/5rfgvqfd
Breakthrough Biotech Builders: Session with Steve Paul · Luma
This discussion would be a private gathering designed to foster high-level dialogue and genuine connections in the area of biotech leadership. We hope that…
luma.com
November 19, 2025 at 8:31 PM
Today Co-Founder & Board Chair Dr. Steve Paul joins Technology Innovation Studio’s Breakthrough Biotech Builders fireside chat on his role in the dev of CNS blockbusters Zyprexa®, Cymbalta® and Cobenfy™ (KarXT) which originated at PureTech (founded/led by @daphnezohar.bsky.social) luma.com/5rfgvqfd
Thanks to the NEVYs for nominating us for the Powerhouse Healthcare Company of the Year at the #NEVYs25Awards! Great progress this year w/ the launch of two clinical trials & we look forward to making a difference for those w/ #neuropsychiatric conditions: bit.ly/nevy25
November 14, 2025 at 3:06 PM
Thanks to the NEVYs for nominating us for the Powerhouse Healthcare Company of the Year at the #NEVYs25Awards! Great progress this year w/ the launch of two clinical trials & we look forward to making a difference for those w/ #neuropsychiatric conditions: bit.ly/nevy25
Tune in today at 10:00AM EST as our CFO, Lauren White, & CSO, Michael Chen, present at the Stifel 2025 Healthcare Conference. The team will also participate in 1x1 meetings while at the conference.
Tune in: bit.ly/4oNTUBA
Replay available here: bit.ly/43Nvu33
Tune in: bit.ly/4oNTUBA
Replay available here: bit.ly/43Nvu33
November 11, 2025 at 12:00 PM
Tune in today at 10:00AM EST as our CFO, Lauren White, & CSO, Michael Chen, present at the Stifel 2025 Healthcare Conference. The team will also participate in 1x1 meetings while at the conference.
Tune in: bit.ly/4oNTUBA
Replay available here: bit.ly/43Nvu33
Tune in: bit.ly/4oNTUBA
Replay available here: bit.ly/43Nvu33
Members of our management team will present at the Stifel 2025 Healthcare Conference on November 11 at 10:00AM ET. The team will also participate in 1x1 meetings during the conference.
Press release: bit.ly/49x28cP
Live & archived webcast here: seaporttx.com/news-papers/
Press release: bit.ly/49x28cP
Live & archived webcast here: seaporttx.com/news-papers/
November 4, 2025 at 12:01 PM
Members of our management team will present at the Stifel 2025 Healthcare Conference on November 11 at 10:00AM ET. The team will also participate in 1x1 meetings during the conference.
Press release: bit.ly/49x28cP
Live & archived webcast here: seaporttx.com/news-papers/
Press release: bit.ly/49x28cP
Live & archived webcast here: seaporttx.com/news-papers/
Happy Halloween! We had so much fun celebrating together w/ themed team costumes & plenty of laughs. These gatherings remind us how connection energizes our shared commitment to developing new medicines for people living w/ #neuropsychiatric conditions like #depression & #anxiety.
October 31, 2025 at 6:09 PM
Happy Halloween! We had so much fun celebrating together w/ themed team costumes & plenty of laughs. These gatherings remind us how connection energizes our shared commitment to developing new medicines for people living w/ #neuropsychiatric conditions like #depression & #anxiety.
Co-Founder & CEO, @daphnezohar.bsky.social joined an all-women Rare & Neuro Diseases panel at #USAIC25 (watch: bit.ly/3LcJkWg) & gave a shoutout to the Biotech CEO Sisterhood in her opening remarks (view: bit.ly/3X1WPKY).
Join us at #USAIC26: bit.ly/4oEvmei
Join us at #USAIC26: bit.ly/4oEvmei
October 28, 2025 at 11:00 AM
Co-Founder & CEO, @daphnezohar.bsky.social joined an all-women Rare & Neuro Diseases panel at #USAIC25 (watch: bit.ly/3LcJkWg) & gave a shoutout to the Biotech CEO Sisterhood in her opening remarks (view: bit.ly/3X1WPKY).
Join us at #USAIC26: bit.ly/4oEvmei
Join us at #USAIC26: bit.ly/4oEvmei
“We Own It” is a core value of ours & captures our entrepreneurial spirit. Co-Founder & CEO, @daphnezohar.bsky.social, shows us how it's done. Named a Goldman Sachs Most Exceptional Entrepreneur, she inspires us to push boundaries so we can best serve those with #neuropsychiatric conditions.
October 17, 2025 at 11:01 AM
“We Own It” is a core value of ours & captures our entrepreneurial spirit. Co-Founder & CEO, @daphnezohar.bsky.social, shows us how it's done. Named a Goldman Sachs Most Exceptional Entrepreneur, she inspires us to push boundaries so we can best serve those with #neuropsychiatric conditions.
Board member, Denice Torres, shared her expertise on happiness, a core value & key to our work. We aim to increase happiness worldwide & develop novel medicines for #neuropsychiatric conditions. This #WorldMentalHealthDay, we’re reminded that happiness & mental health are linked.
October 10, 2025 at 11:01 AM
Board member, Denice Torres, shared her expertise on happiness, a core value & key to our work. We aim to increase happiness worldwide & develop novel medicines for #neuropsychiatric conditions. This #WorldMentalHealthDay, we’re reminded that happiness & mental health are linked.
Members of our exec team joined Fierce Biotech’s #Fierce15 awards to celebrate our recognition, honoring our team's work developing new medicines for #depression & #anxiety. It's also a reflection of the strong momentum & growth since our launch last year. bit.ly/3VSOQQ7
October 9, 2025 at 6:36 PM
Members of our exec team joined Fierce Biotech’s #Fierce15 awards to celebrate our recognition, honoring our team's work developing new medicines for #depression & #anxiety. It's also a reflection of the strong momentum & growth since our launch last year. bit.ly/3VSOQQ7
We convened top neuropsych experts, sell-side analysts, investors, & biopharma leaders for a unique roundtable discussion on the opportunities & excitement in #neuropsychiatry & what’s next as #MentalHealth conditions continue to impact millions globally. See below for some takeaways
October 8, 2025 at 11:02 AM
We convened top neuropsych experts, sell-side analysts, investors, & biopharma leaders for a unique roundtable discussion on the opportunities & excitement in #neuropsychiatry & what’s next as #MentalHealth conditions continue to impact millions globally. See below for some takeaways
Tune in today at 11:45 AM ET to hear our CFO Lauren White & COO Eric Green present at the Oppenheimer Private Life Sciences Company Showcase. Live webcast: bit.ly/4nllNke & replay available on our website: seaporttx.com/news-papers/
September 25, 2025 at 11:00 AM
Tune in today at 11:45 AM ET to hear our CFO Lauren White & COO Eric Green present at the Oppenheimer Private Life Sciences Company Showcase. Live webcast: bit.ly/4nllNke & replay available on our website: seaporttx.com/news-papers/
We’re a Fierce Biotech Fierce 15 winner! Our Glyph platform, proven team, & focus on validated mechanisms put us among the most “innovative & visionary” companies as we advance clinical programs aiming to deliver new medicines for #depression & #anxiety. bit.ly/4msojnm
September 22, 2025 at 4:02 PM
We’re a Fierce Biotech Fierce 15 winner! Our Glyph platform, proven team, & focus on validated mechanisms put us among the most “innovative & visionary” companies as we advance clinical programs aiming to deliver new medicines for #depression & #anxiety. bit.ly/4msojnm
Looking forward to two upcoming investor conferences: 1x1s & company presentation at Oppenheimer's Private Life Sciences Company Showcase on 9/25 at 11:45am ET & 1x1s at the 5th Annual Needham Private Biotech & MedTech Company Forum, held 10/14-10/15. bit.ly/42z6Fr1
September 18, 2025 at 11:04 AM
Looking forward to two upcoming investor conferences: 1x1s & company presentation at Oppenheimer's Private Life Sciences Company Showcase on 9/25 at 11:45am ET & 1x1s at the 5th Annual Needham Private Biotech & MedTech Company Forum, held 10/14-10/15. bit.ly/42z6Fr1
Pleased to share the first participant has been dosed in our Ph1 study of GlyphAgo™ (SPT-320). This is our 2nd therapeutic candidate in clinical development & represents an important clinical advancement for patients w/GAD. bit.ly/4meQFl0
September 11, 2025 at 11:09 AM
Pleased to share the first participant has been dosed in our Ph1 study of GlyphAgo™ (SPT-320). This is our 2nd therapeutic candidate in clinical development & represents an important clinical advancement for patients w/GAD. bit.ly/4meQFl0